Related references
Note: Only part of the references are listed.Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study
David E. Tabor et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season
Johan L. Van der Plas et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis
Renato T. Stein et al.
PEDIATRIC PULMONOLOGY (2017)
ICTV Virus Taxonomy Profile: Pneumoviridae
Bert Rima et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins
Sandra Fuentes et al.
PLOS PATHOGENS (2016)
Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
Zhiwu Sun et al.
VIRUSES-BASEL (2013)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Seroprevalence of human respiratory syncytial virus and human metapneumovirus in healthy population analyzed by recombinant fusion protein-based enzyme linked immunosorbent assay
Patricia Sastre et al.
VIROLOGY JOURNAL (2012)
The host response and molecular pathogenesis associated with respiratory syncytial virus infection
Christine M. Oshansky et al.
FUTURE MICROBIOLOGY (2009)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
PA Piedra et al.
VACCINE (2003)
Share Paper
